Moog Medical Devices Group announces voluntary recall of select Curlin administration sets due to possible health risk


Intravenous news: FDA report “Moog Medical Devices Group (MMDG) is issuing a voluntary recall for certain lots of Curlin Intravenous Administration Sets. Use of the affected sets may cause desanguination (blood loss), an under-delivery of prescribed medication/fluid, or a potential delay in therapy. Continued use of the affected administration sets may cause a potential risk of serious injury or death.

Click here for the full story.

Main page


Comments are closed.